Erasca Newsroom

H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsApr 30 14:31 ET

Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow JonesApr 30 06:52 ET

Erasca Analyst Ratings

BenzingaApr 30 06:42 ET

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsApr 28 14:31 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)

TipRanksApr 28 06:48 ET

Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsMar 31 14:32 ET

Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)

TipRanksMar 31 08:10 ET

Erasca (ERAS) Gets a Buy From J.P. Morgan

TipRanksMar 30 09:59 ET

Raymond James Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $5

Moomoo NewsMar 26 14:31 ET

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsMar 26 14:31 ET

Raymond James Initiates Erasca at Outperform With $5 Price Target

MT NewswiresMar 26 07:08 ET

Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), Erasca (ERAS)

TipRanksMar 26 06:35 ET

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsMar 21 15:32 ET

H.C. Wainwright Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $6

Moomoo NewsMar 21 15:32 ET

Erasca Price Target Cut to $3.00/Share From $3.50 by Goldman Sachs

Dow JonesMar 21 10:15 ET

Erasca Is Maintained at Buy by Goldman Sachs

Dow JonesMar 21 10:15 ET

Erasca Analyst Ratings

BenzingaMar 21 08:19 ET

Erasca Analyst Ratings

BenzingaMar 7 12:27 ET

Morgan Stanley Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $4

Moomoo NewsMar 7 07:31 ET

BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsJan 15 05:32 ET